|
|
|
|
| Symbol(s): |
GXDX |
| Date: |
7-Feb-10 |
| Contributor: |
PriceTarget Research, Inc. |
| Title: |
Genoptix has a current Overall Rating of C (Neutral). |
| Document Size: |
7 pages |
| Price: |
$25 |
| Document Type: |
Adobe Acrobat Reader®
Download free Adobe Acrobat Reader® |
|
| Research Reports Premium Services |
| ·
|
Get the full report for $25. |
| ·
|
You will have access to this report for 24 hours. |
|
|
|
|
|
| Genoptix has a current Overall Rating of C (Neutral). Power Rating (65) is high; appreciation potential (42) is neutral. Relative to the S&P 500 Composite, Genoptix Inc has significant Growth characteristics -- its appeal is likely to be to Capital Gain-oriented investors. GXDX is of low investment quality. Genoptix's current technical position is very strong. Genoptix's Power Rating is 65. The recent trend in GXDX's earnings estimates has been favorable. Genoptix's Medical...
| | |
|
|
